ARTICLE | Financial News
Atossa proposes follow-on
February 17, 2017 7:56 PM UTC
On Feb. 13, drug delivery and cancer company Atossa Genetics Inc. (NASDAQ:ATOS) proposed to raise up to $4 million in a follow-on underwritten by Aegis Capital....
BCIQ Company Profiles